EAST RUTHERFORD, N.J., April 23, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback